Mar. 11 at 3:13 AM
$NPHC I don’t think the company necessarily folds. They still have pharmaceutical projects and other consumer products like energy drinks, so the business itself could continue operating.
The bigger issue is the stock. With the Caveat Emptor designation, most brokers restrict trading and liquidity disappears. Once a stock ends up in that status, it’s extremely difficult to regain normal trading unless the company becomes fully current with filings and disclosures.
Their overall revenue is very small compared to their debt load. Even if the company keeps operating with pharmaceutical products or beverages, the financial structure makes it hard to see how the equity side benefits.
So my view isn’t that the company disappears, it’s that the stock itself may never return to normal trading.
